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There is now strong evidence that the ultraviolet A (UVA) part of the solar spectrum contributes to the development
of skin cancers. Its effect on the skin immune system, however, has not been fully investigated. Here, we analyzed
the effects of UVA radiation on dermal dendritic cells (DDC), which, in addition, provided further characterization of
these cells. Dermal sheets were obtained from normal human skin and irradiated, or not, with UVA at 2 or 12 J per
cm2. After a 2 d incubation, the phenotype of emigrant cells was analyzed by double immunostaining and ﬂow
cytometry. Results showed that migratory DDC were best characterized by CD1c expression and that only few cells
co-expressed the Langerhans cell marker Langerin. Whereas the DC extracted from the dermis displayed an im-
mature phenotype, emigrant DDC showed increased expression of HLA-DR and acquired co-stimulation and mat-
uration markers. We showed here that UVA significantly decreased the number of viable emigrant DDC, a process
related to increased apoptosis. Furthermore, UVA irradiation impaired the phenotypic and functional maturation of
migrating DDC into potent antigen-presenting cells, in a concentration-dependent manner. The results provide
further evidence that UVA are immunosuppressive and suggest an additional mechanism by which solar radiation
impairs immune response.
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Exposure to ultraviolet (UV) radiation is the major cause of
most skin cancers. Historically, most studies have concen-
trated on UVB (290–320 nm), which constitute the most
energetic part of the solar spectrum at the earth’s surface.
Based on DNA absorption spectrum, UVB directly induced
mutations and chromosomal damage and was therefore
considered more carcinogenic than UVA (320–400 nm) (De
Gruijl et al, 1993). Furthermore, UVB is highly immunosup-
pressive, a process that plays a key role in tumor progres-
sion. UVB-induced immunosuppressive effect has been
well characterized and related to multiple mechanisms in-
cluding DNA damage, cytokine production, and direct al-
teration of Langerhans cell (LC) antigen-presenting function
(Duthie et al, 1999).
UVB radiation, however, only comprises about 5% of the
solar UV that reaches the biosphere, whereas UVA are 20
times more abundant. Furthermore, UVA penetrates deeper
into the skin and, upon exposure to sunlight, 100 times
more UVA than UVB photons reach the dermis. UVA radi-
ation has been shown to cause DNA damage and muta-
tions, mostly through the generation of oxygen/nitrogen
species, which then interact with various molecular com-
ponents (Halliday et al, 1998). Recently, there has been
compelling evidence that UVA contributes to UV-induced
immune-suppression. Indeed, UVA exposure of human skin
results in decreased induction of contact sensitisation and
induced tolerance (LeVee et al, 1997; Moyal and Fourtanier,
2001). UVA is the critical wavelength for suppressing es-
tablished immune response to Candida albicans in mice
(Nghiem et al, 2001). Furthermore, sunscreen studies indi-
rectly confirmed that UVA are immunosuppressive by show-
ing that products with high UVA absorption afforded a
higher degree of immune protection than the products with
low UVA protection, despite equal filtration of UVB (Damian
et al, 1997; Moyal and Fourtanier, 2001; Baron et al, 2003;
Poon et al, 2003). Despite the demonstration of UVA overall
immunosuppressive effect, the impact of the radiation on
the skin immune system has received relatively little re-
search attention. The few studies only concern epidermal
LC, whose allostimulatory function was altered by UVA
(Clement-Lacroix et al, 1996).
Due to their accessibility, LC are the best-characterized
DC. The cells exhibit some characteristic features such as
expression of CD1a and Langerin, a major constituent of
Birbeck granules (Valladeau et al, 2000). Moreover, numer-
ous studies have established the critical role of LC in ini-
tiating skin immune responses, due to their ability to take up
antigens that cross the epidermal barrier, migrate to re-
gional lymph nodes, and present pre-processed antigens to
naı¨ve T cells (Steinman, 1991). By contrast, DC populating
the dermis are still poorly defined. Early studies have dem-
onstrated their potent role in skin sensitization to allergens
(Streilein, 1989), or antigen presentation (Sepulveda-Merrill
et al, 1994; Nestle et al, 1998). Some recent papers suggest,
however, that dermal DC (DDC) may differ from LC regard-
ing antigen presentation (Pena-Cruz et al, 2003; Ritter et al,
Abbreviations: DDC, dermal dendritic cells; LC, Langerhans cells;
UV, ultraviolet
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2004) or Th1 versus Th2 orientation of the T cell response
(Strid et al, 2004). Since UVA enters the dermis, DDC might
be potent targets of the radiations. In this study, we sought to
analyze the effects of UVA radiation on human DDC, which,
besides, will provide further characterization of these cells.
Results
Characterization of emigrant dermal cells We first char-
acterized, by flow cytometry, the cells that had spontane-
ously migrated from the dermis after a 48 h culture in
serum-free medium. Viability of the cells always exceeded
90%, as assessed by trypan blue exclusion. According to
the donors, the mean number of migratory cells per gram of
dermis was 5  105  7  104 (n¼ 6). In eight experiments,
the relative proportion was 21%  11% CD3þ T cells,
2.4%  1.1% CD19þ B lymphocytes, and 8.0%  5.2%
CD14þ monocytes/macrophages. CD16þ cells, i.e.,
neutrophil granulocytes and macrophages (CD36þ cells)
were present in a negligible proportion. Importantly, Langerin-
positive LC never exceeded 4% of the total migrating cells.
CD45 cells, most probably keratinocytes and fibroblasts,
represented between 15% and 35% of the total cell sus-
pension. Finally, the percentage of DC, as identified by
CD1c expression at their surface, averaged 52%  10%.
Under a phase-contrast microscope, the cells could be
easily identified by their dendritic processes and quite re-
sembled cultured LC (not shown).
Using flow cytometry (FACS) analysis, the dendritic le-
ukocytes could be easily distinguished from most other cell
types by forward scatter (FSC) and side scatter (SSC) pro-
files. As depicted in Fig 1A, small cells, corresponding to
B and T cells, could be easily distinguished from the large
cells corresponding to DC. CD45 non-leukocyte popula-
tion was scattered in the FSC/SSC plot, but quite excluded
from the dendritic population. By contrast, CD14þ cells
were included in the DC cloud.
Double staining showed that a large majority of CD45þ
and HLA-DRþ cells were DC, as they co-expressed CD1c
or CD1a, the other HLA-DRþ populations being identified
as Tcells, B cells, or monocytes (Fig 1B). In fact, in five experi-
ments, the total amount of HLA-DRþ cells (71.3%  5.1%)
was equivalent to the total of HLA-DRþ /CD1cþ DC
(57.6%  5.3%), HLA-DRþ /CD3þ T cells (4.1%  2.5%),
HLA-DRþ /CD14þ monocytes (9.1%  1.9%), CD16þne-
utrophils (1.1%  0.9%) and HLA/DRþ /CD20þ B cells
(1.0%  0.8%), therefore demonstrating that all dermal DC
are in the CD1cþ population. Virtually, all CD1cþ cells were
CD11bþ and CD11cþ . None of CD1cþ cells expressed the
CD3 T cells marker. All the CD1aþ cells were CD1cþ ,
whereas a minor population of CD1cþ (5%–10%) cells did
not express CD1a (Fig 1B). Very few cells co-expressed
CD1c and CD14 antigens, or CD1c and Langerin, whereas
most CD1cþ cells expressed the factor XIIIa (Fig 1B). In-
terestingly, CD36 expression was found on a small per-
centage of dermal CD1cþ DC as well as CD1aþ DC (not
shown). It should be noted that DC-SIGN expression was
undetectable on the migratory dermal cells (not shown).
CD1c is known to be present at the surface of a small
subset of B cells. In our experiments, however, neither
CD20þ (Fig 1B) nor CD19þ B cells (not shown) were CD1cþ ,
suggesting that the B subset is not present in the dermis.
UVA radiation induces DDC apoptosis We investigated
whether UVA irradiation would modify the total number
or proportion of emigrant viable dermal cells. In a series
of six experiments, the number of viable emigrant cells
per g of dermis was not altered after irradiation at 2 J
per cm2. By contrast, it was significantly decreased after
irradiation at 12 J per cm2 (263.8  103 vs 499.8  103 cells
per g of dermis, po0.001).
The relative proportion of CD3þ T cells was increased
(18.7%  9.8%, 30.4%  6.2%, and 27.1%  6%), where-
as that of CD1cþ was concomitantly decreased
(56.6%  9.3%, 43.4%  9.3%, and 33.9%  9.2%) after
irradiation at 0, 2, and 12 J per cm2, respectively (mean from
five experiments).
Given the concentration-dependent decrease in the total
number of emigrant cells and in the proportion of DDC, we
hypothetized that this effect might be due to an induction of
cell apoptosis. To verify this possibility, cells were stained
Figure1
Phenotypic profile of dermal migrating cells. After 48 h incubation of
human dermis in serum-free medium, migrating cells were recovered
and processed for flow cytometry. (A) Forward and side scatter
identification of the different cell subsets, including dermal dendritic
cells (within the gate). (B) Double staining of dermal cells with either
anti-CD1c or anti-HLA-DR and the indicated monoclonal antibodies.
The total dermal cell suspension was analyzed without any gating.
The quadrant gates were set up according to the negative control Ig.
The results are representative of at least seven experiments carried out
with different donors.
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using Annexin V—fluorescein isothiocyanate (FITC) mono-
clonal antibody (mAb) and propidium iodide (PI). Cell anal-
ysis was then carried out on either the total migrating cell
population or DDC, by gating the cells according to FSC/
SSC parameters, as described in Fig 1A. In a series of four
experiments, we observed that the percentage of dead and
apoptotic cells in the total dermal cell population tended to
increase upon UVA irradiation, but the effect was not sig-
nificant, as assessed by Student’s t test (data not shown).
When we focused on DDC, however, we observed a sig-
nificant increase (po0.05), in the percentage of both apo-
ptotic and necrotic cells (Fig 2A and B) after irradiation at
12 J per cm2. The data suggest that the higher dose of UVA
increases DDC death, in a significant way.
UVA irradiation impairs the maturation of human mi-
grating dermal DC In order to assess the effects of UVA
radiation on the activation/maturation markers on migrating
DDC, we first analyzed the phenotypic status of freshly
isolated DDC. After enzymatic digestion of human dermis,
resident DDC represented about 10% of the dermal cell
population, as identified by CD1 expression (9.2%  1%
CD1aþ and 11.5%  1.1% CD1cþ cells, mean from three
experiments). Double staining (Fig 3A) showed that all
CD1cþ or CD1aþ cells (not shown) co-expressed CD45
and HLA-DR, whereas none of them were CD3þ , CD14þ ,
or CD20þ . CD36 was expressed on about half the CD1c
population. Whereas almost all CD1cþ were factor XIIIþ
(not shown), very few cells (about 6%) co-expressed La-
ngerin. In agreement with a recent paper (Turville et al,
2002), we found that only a minor DDC subset (about 7%)
were DC-SIGNþ . Interestingly, we consistently noticed a
DC SIGNþ /CD1c- population. Using triple staining, this
population was identified as CD45 and most probably
represented endothelial cells (not shown).
As shown in Fig 3B, most of the freshly isolated CD1cþ
DC are immature since they did not express CD40, CD54,
CD80, CD83, CD86, CCR7, and DC-LAMP Ag. By contrast,
upon 48 h incubation, emigrant DDC acquired a mature
phenotype, as evidenced by higher expression of HLA-DR,
as well as acquisition of most above-mentioned Ag (Fig 3B).
Although CD1c expression remained constant, CD1a ex-
pression was downregulated on migratory, as compared
with resident DDC (Fig 3B). When the protease digestion
cocktail was added to mature migrating dendritic cells, the
treatment did not markedly alter the DDC phenotype (not
shown), thus demonstrating that the immature state of
freshly isolated DDC was not related to protease treatment.
We next analyzed the effects of UVA on the phenotype of
emigrant DDC using double staining and gating on CD1cþ
cells. Table I gives the mean results from at least four in-
dependent assays. As compared with sham-irradiated cells,
UVA irradiation induced a significant decrease in the per-
centage of DDC that acquire co-stimulatory molecules
(CD40, CD80, CD86) as well as maturation markers (CD83
Figure 2
Ultraviolet A (UVA) irradiation promotes the apoptotic death of
human dermal dendrtic cell (DDC). Human dermis was irradiated, or
not, with UVA at 2 or 12 J per cm2 and incubated for 48 h in serum-free
medium. Migrating cells were then recovered and analyzed for
apoptosis using annexin V and propidium iodide staining. (A) DDC
were analyzed by flow cytometry, after gating on FSC/SSC parameters
according to Fig. 1A. Apoptotic cells are located in the lower right
quadrant and necrotic cells in the upper right quadrant. Numbers rep-
resent the percentage of cells in each quadrant. (B) Results from four
independent experiments showing the mean percentage  SD of apo-
ptotic and necrotic cells, as defined in A. Results statistically different
(po0.005) from the non-irradiated control.
Figure 3
Phenotypic profiles of resident versus migrating human dermal dendrtic cell (DDC). (A) Human dermis was digested for 2 h with an enzymatic
cocktail. The resident dermal cells were recovered and double stained with anti-CD1c and the indicated monoclonal antibodies (mAb). Cells were
analyzed by flow cytometry, without any gating. (B) Activation/maturation status of freshly isolated versus migrating DDC. Dermal cells were
recovered either after dermis digestion or after a 2-d migration from dermis. Cells were double stained with anti-CD1c and the indicated mAb and
analyzed by flow cytometry.
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and CCR7). These modifications were concentration
dependent and already observed after the lower dose of
irradiation for CD40, CD80, and CD83 antigens. Similarly,
the percentage of HLA-DR and DC-LAMP CD1cþ cells
tended to decrease on irradiated DDC. The percentage of
CD1aþ DDC only decreased after dermis irradiation at 12 J
per cm2. The mean fluorescence intensity of all antigens
was consistently, although not significantly, decreased,
suggesting that some DDC could escape the UVA delete-
rious effect (not shown). It is of note that gating out the dead
cells using propidium iodide did not significantly alter the
results, suggesting that the decreased number of mature
DDC after irradiation did not merely reflect UVA-induced
necrosis (not shown).
In order to assess whether UVA-induced altered DDC
maturation could be related to increased apoptosis, double
staining was carried out using FITC–annexin. Upon UVA ir-
radiation, most CD1cþ /annexinþ apoptotic cells failed to
acquire the activation/maturation markers CD83 or CD86
(not shown).
UVA alters the allostimulatory capacity of human
DDC Emigrant dermal cells from irradiated or sham-irradi-
ated dermis were then evaluated for their capacity to induce
allogeneic T cell proliferation. To this end, graded numbers
of viable dermal cells were added to T cells. As shown in Fig
4A, the total dermal cell allostimulatory function was signif-
icantly reduced after irradiation at 12 J per cm2. The results
were still more significant when corrected according to the
number of viable DDC, i.e. CD1cþ /IP- cells, in the suspen-
sions (Fig 4B). The results demonstrated that UVA irradia-
tion decreased the ability of DDC to present antigen to T
lymphocytes and therefore reduced the efficiency of im-
mune response.
Discussion
The aim of this study was double: (1) to extend the char-
acterization of human dermal DC and (2) to analyze the
effects of UVA irradiation on the phenotypic and functional
properties of these cells. To this end, dermal sheets were
irradiated and DC collected by using their spontaneous
migratory property.
The technique we used to recover emigrant dermal cells
was similar to those previously described (Lenz et al, 1993;
Nestle et al, 1993), except that we used serum-free medium
and left the dermal pieces whole instead of cutting
them into small fragments. This, respectively, avoids serum
factors that might induce DDC maturation and substantially
decreased the relative number of non-hematopoietic cells
in the migratory cell suspension (personal observation,
not shown).
Dermal resident or emigrant DC had been most fre-
quently identified using HLA-DR and/or CD1a expression
(Lenz et al, 1993; Meunier et al, 1993; Nestle et al, 1993;
Sepulveda-Merrill et al, 1994; Turville et al, 2002). Apart from
DDC, however, HLA-DR stained many migratory T cells and
monocytes, as well as resident non-hematopoietic dermal
cells. Moreover, as opposed to CD1c, CD1a expression
decreased upon DDC migration. This might explain why a
subset of CD1cþ cells was CD1a. We found here that anti-
Table I. Phenotype of migrating dermal dendritic cells
DR CD1a CD40 CD54 CD80 CD86 CD83 CCR7 DC-LAMP
n 4 4 6 5 5 6 6 5 4
Non-irradiated 97.8  1.4 69.2  15.5 67.5  18.5 41.4  10.1 46.8  12.3 89.7  4.5 68.8  8.5 55.7  16 67.6  8.1
2J/cm2 94  3.8a 62  17.6a 56.7  23.1b 36.4  14.4 30.8  12c 79.3  12.2 56.8  10.6a 45.7  18.2 55.9  6.8
12J/cm2 86.1  15.4 48.6  21.3a 44.2  23.8b 37  18.4 20.4  13.7b 68.2  15.3b 38  12.9c 37  15.9a 53.6  10.9
Human dermis was irradiated, or not, with UVA at 2 or 12 J per cm2 and incubated for 48 h in serum-free medium. Migrating cells were then recovered
and CD1cþ population was gated and analyzed for activation/maturation markers. Data represent the mean percentage of positive cells (  SD) and n
gives the number of independent experiments. Statistical significance was assessed using the Student’s t test. Values of po0.05 were considered
statistically significant, apo0.05, bpo0.01, cpo0.005.
UVA, ultraviolet A.
Figure4
Ultraviolet A (UVA) alters the allostimulatory function of human
dermal dendrtic cell. Human dermis was irradiated, or not, with UVA
at 2 or 12 J per cm2 and incubated for 48 h in serum-free medium.
Migrating cells were then recovered, and graded number of viable cells
was added to purified allogeneic T cells. After 5 d, T cell proliferation
was assessed by the addition of 3H-thymidine for 18 h. Results are the
mean  SD of triplicate wells and representative of four experiments.
The cpm of T cells alone never exceeded 50. The stimulator cell num-
bers correspond to either total migratory dermal cells (A) or was cor-
rected according to the percentage of viable CD1cþ cells in the
suspensions, as assessed by flow cytometry analysis (B).
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CD1c mAb most selectively identify DDC and might
therefore be very useful for the cell purification. The results
agree with in situ staining that reveals far higher reactivity
in the dermis using anti-CD1c, as compared with anti-CD1a
mAb (Nestle et al, 1993; Gerlini et al, 2001). Moreover,
previous studies showed that anti-CD1c mAb react with
all emigrant dermal DC cells, purified by cell sorting
according to high forward and side scatter properties
(Meunier et al, 1993), or selected on HLA-DRbright expres-
sion (Gerlini et al, 2001). Lastly, the allostimulating property
of dermal DC has been related to the CD1cþ subset
(Meunier et al, 1993).
Mainly because of CD1 expression, the bulk of dermal
DC has long been related to epidermal LC. Indeed, it was
thought to be LC precursors on their way to the epidermis
and, especially, epidermal LC on their way to lymph nodes.
The recent discovery of Langerin (Valladeau et al, 2000),
which selectively identifies LC, revealed that only scarce
Langerin-expressing cells were present in the dermis, as
assessed by immunohistological studies of both murine and
human skin (Valladeau et al, 1999; Ebner et al, 2004). In
agreement with a recent paper (Ebner et al, 2004), we con-
firmed here, by flow cytometry, that very few migrating DDC
were Langerinþ and extended the results to resident DDC.
Since the antigen was substantially expressed on LC after
extraction and in vitro culture (Stoitzner et al, 2003; and
personal observation) it is unlikely that the antigen may be
lost on dermal DC following in vitro preparation or migration
from the dermis. Finally, the recently described very low
turnover of LC cells under steady state (Merad et al, 2002) is
in line with the assumption that most dermal DC represent a
resident population of DC.
In a recent paper, Larregina et al (2001) described a
CD14þ /Langerinþ population that migrated from whole-
skin explants and differentiated into LC upon in vitro culture.
Here we found some migrating CD14þ cells but, in agree-
ment with others (Ebner et al, 2004), we never detected
Langerin expression in these cells.
CD36þ cells were known to re-colonize the epidermis
following UVB-induced LC depletion (Cooper et al, 1986).
As opposed to Lenz et al (1993), who found that all DDC
expressed CD36 by gating the cells according to high HLA-
DR expression, we here reported CD36 expression on a
sub-population of CD1cþ or CD1aþ DDC, suggesting that
these cells might be LC precursors.
Only few data are available concerning the activation/
maturation status of human DDC. Our observations confirm
and extend previous studies showing that the bulk of re-
sident DDC are immature. In contrast, most migrating DDC
strongly expressed the maturation marker DC-LAMP as well
as CCR7, a prerequisite for skin DC migration to occur (Ohl
et al, 2004). This supports a full role of dermal DC popu-
lation in skin immune responses. Inasmuch as these cells
differ from the epidermal DC, especially regarding C-type
lectins as well as CD1 expression (Pena-Cruz et al, 2003;
Ebner et al, 2004), the respective role of each cell population
in the skin immune response remains to be defined. For
example, a recent paper demonstrated that, in mice, delive-
ry of a protein antigen into the dermis gave predominantly
Th1 responses, whereas antigen presentation by LC was
strongly Th2 biased (Strid et al, 2004).
As opposed to UVB, a large part of solar UVA radiation
enters the human dermis. There is now strong evidence that
UVA contributes to the development of skin cancers (Kelfk-
ens et al, 1991; Wang et al, 2001), but its effect on the
immune system is less well defined. Despite conflicting data
in the literature, showing that a high dose of UVA can pro-
tect hairless mice from UVB-induced immune suppression
(Reeve et al, 1998), there has recently been a greater
awareness regarding its immunosuppressive role. For ex-
ample, UVA was shown to augment solar-simulated UV-in-
duced local suppression of recall responses to nickel in
humans (Kuchel et al, 2002). The mechanism was thought
to involve LC, the epidermal DC known to play a crucial role
in the initiation of skin immune responses. Indeed, UVA ir-
radiation decreased the number of LC in human epidermis
(Dumay et al, 2001) and was shown to inhibit the in vitro
allostimulatory (Clement-Lacroix et al, 1996) or hapten-pre-
senting function of LC (Iwai et al, 1999) in a concentration-
dependent manner, a process accompanied by suppres-
sion of CD54, CD80, and CD86 co-stimulatory molecules.
In vivo, UVA-II (320-340 nm) exposure reduced the skin’s
ability to mount contact sensitization and induced active
suppression, a process related to impaired LC antigen-
presenting function (LeVee et al, 1997).
We showed here that UVA irradiation of human dermis
impaired the phenotypic and functional maturation of mi-
grating dermal DC into potent antigen-presenting cells and
induced their apoptosis. This might suggest that, under
in vivo conditions, few efficient DDC would be able to reach
the lymph nodes. The dose of UVA that we used can be
considered as physiologically relevant since about 15 J per
cm2 UVA were received after about fifty minutes exposure to
sunlight. We found that, upon UVA irradiation, the number of
viable emigrant dermal DC was reduced, corresponding to a
cytotoxic effect of UVA, as assessed by annexin staining. As
a consequence, a significant proportion of the viable DC mi-
grating after UVA irradiation failed to acquire the activation/
maturation markers such as CD40, CD86, CD83, CCR7, and
DC-LAMP. This ultimately correlates with an impaired ca-
pacity of the cells to induce allostimulatory T cell response.
Since this experimental approach quite eliminates the
epidermal compartment, one could question its physiolog-
ical relevance. Accordingly, some experiments have been
carried out using whole-skin samples and triple staining.
Skin was irradiated at 15 and 18 J per cm2, a lower dose
than that applied to dermal sheets, considering that about
40% of UVA radiation reach the dermis. The FSC/SSC pro-
file of whole-skin-migrating cells was very similar to that
obtained with dermal sheets, therefore allowing the elimi-
nation of T and B cells for subsequent analysis. By gating
DDC according to CD45þ /Lang staining, we found that
skin irradiation at 15 and 18 J per cm2 induced a decrease in
the percentage of CD1a, CD80, CD83, CD86, and CCR7
expressing DDC, very similar to that obtained after dermal
sheet irradiation. The results suggest that the presence of
the epidermal compartment did not prevent the deleterious
effects of UVA on DDC, and might even strengthen its effect.
Thus, under UVA exposure, alterations of both epidermal
and dermal DC would lead to an alteration of immune re-
sponse. With regard to immune suppression, UVA might be
therefore more harmful than UVB that would only alter ep-
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idermal LC. In line with this, recent studies showed that UVA
protection predicts the ability of sunscreens to provide im-
mune protection in humans (Damian et al, 1997; Moyal and
Fourtanier, 2001; Nghiem et al, 2001; Baron et al, 2003;
Poon et al, 2003). Moreover, when UVB were removed from
solar-simulated UV radiation, there was no observable ef-
fect on the suppression of delayed-type hypersensitivity in
mice, therefore demonstrating that UVA effects dominate
those of UVB (Nghiem et al, 2001; Halliday et al, 2004).
Many of the biological effects of UVA are caused by re-
active oxygen species (Halliday et al, 1998). Indeed, ex-
ogenous glutathion, as well as vitamin E, were found to
reverse the UVA-induced suppression of LC function (Clem-
ent-Lacroix et al, 1996). Although the mechanisms involved in
dermal DC alteration need to be clarified, this suggests that
UVA may alter the immune system via an oxidative pathway.
In conclusion, the results showed that UVA impairs the
phenotypic and functional maturation of human DDC, a full
DC population that represents a second line of defence
behind epidermal LC. This may be, therefore, an additional
mechanism by which solar radiation impairs immune re-
sponse and subsequently induces skin cancer growth. This
mechanism might be especially important during the aging
process, characterized by thinner epidermis and thus in-
creased UVA sensitivity and might explain, at least in part,
the increased frequency of cutaneous cancers in the elderly.
The results underline the importance of protecting the popu-
lation not just from UVB but also from UVA irradiation.
Materials and Methods
Preparation of dermal sheets Normal skin specimens were pro-
vided from plastic abdominal surgery after obtaining the patients’
informed consent. Human skin was freed of fatty tissue and split
cut with a keratome set. The resulting skin stripes were incubated
in Hank’s Balanced Salt Solution (HBSS) (Gibco, Cergy Pontoise,
France) containing 1% gentamycin (Sigma, L’isle d’Abeau Ches-
nes, France) and 0.25% dispase II (Roche, Meylan, France) during
1 h at 371C in 5% CO2. Epidermal sheets were then stripped off the
dermal layer using forceps. Dermal pieces were washed twice in
HBSS, 1% gentamycin. This protocol was approved by the insti-
tutional review board of the University Claude Bernard Lyon1 and
is in accordance with the Declaration of Helsinki.
Irradiation of dermal sheets Dermal sheets were layered into 100
mm + Petri dishes in X-Vivo medium (Cambrex, Emerainville,
France), 1% gentamycin and exposed to different doses of UVA
radiation. The UVA source was a bank of four tubes emitting from
320 to 400 nm with a peak at 365 nm (Biosun apparatus, Vilber
Lourmat, Marne la Valle´e, France). The detector is a radiometer with
a precision of  5%, according to the reference radiometer
VLX1.3W. The precision of the intensity measure is  0.2%. The
mean distance from the lamp to the irradiated cells is 23 cm. Two
doses were used in this study: 2 and 12 J per cm2. After irradiation,
or after a corresponding sham-irradiation period (control), each sam-
ple was incubated at 371C in 5% CO2 during 48 h for cell migration.
Collect of emigrant dermal cells Non-adherent cells that had
migrated out of the dermal explants were collected by filtrating the
culture medium through a sterile gauze. The explants were washed
twice, and the emigrant cell suspension was obtained after a 10
min centrifugation at 400  g. The viability of cell suspensions from
UVA- or sham-irradiated dermal sheets was determined by trypan
blue exclusion.
Preparation of dermal cell suspension In some experiments,
cells were extracted from freshly prepared dermis. To this end,
dermal sheets were incubated during 2 h at 371C, under gentle
agitation, in RPMI-1640 (Gibco), 1% gentamycin, 1 mg per mL col-
lagenase (Sigma), 1 mg per mL hyaluronidase (Sigma), and 100 mg
per mL DNaseI (Sigma). The digestion medium was then filtrated
through a sterile gauze to obtain total dermal cell suspension.
Flow cytometry Cells were incubated for 30 min at 41C with af-
finity-purified mAb at the appropriate concentration or with irre-
levant isotype-matched mouse Igs at the same concentration. In
some experiments, viable cells were analyzed excluding PI-pos-
itive cells. The following mAb were used: anti HLA-DR-FITC
(B8.122), anti CD54-FITC (84H10), anti CD80-FITC (MAB104),
anti CD83-FITC (HB15a), anti DC-LAMP-PE (104.G4), anti-Langerin-
PE (DCGM4), all from Immunotech (Marseille; France), anti CD40-
FITC (clone EA-5) from Biosource International (Nivelles, Belgium),
anti CD45-FITC (HI30), anti CD86-FITC (FUN-1), anti CD19-FITC
(HIB19), all from BD Biosciences (Pont de Claix, France), anti
CCR7-FITC (150503), anti DC-SIGN-FITC (DCN46) from R&D sys-
tem (Lille, France), anti CD1a-FITC (clone NA1/34), anti CD3-FITC
(UCHT1), anti CD14-FITC (TU¨K4), anti CD16-FITC (DJ130c), anti
CD20-FITC (B-Ly1), all from DAKO (Trappes, France), and anti
CD1c-PE (AD5-8E7) from Miltenyi Biotec (Paris, France).
For double-color fluorescence, FITC- and PE-conjugated mAb
were incubated at the same time. Intracellular stainings were per-
formed using the Fix and Perm kit from DAKO. After incubation
with the antibodies, cells were washed and re-suspended in phos-
phate-buffered saline, 1% bovine serum albumin, and 0.02% so-
dium azide. Fluorescence analysis was performed on a FACScan
using LYSIS II software (BD Biosciences).
Apoptosis Quantification of apoptotic cells was assessed using
an apoptosis kit (Immunotech). The early exposure of phosphati-
dylserine residues at the surface of apoptotic cells was measured
using Annexin V–FITC staining, with dead cells identified by PI.
Allogeneic T cell proliferation assays Human T cells were pu-
rified from normal human blood by the rosetting method, using
2-amino-ethylisithiouronium bromide hydroxy-bromide-treated
sheep red blood cells, as previously described (Kaplan and Clark,
1974). Graded numbers of viable dermal cells were used as
stimulators of 105 Tcells in RPMI-1640 medium supplemented with
10% normal human AB serum (EFS, Lyon, France). Cultures were
established in triplicate and maintained in 96-well round-bottomed
plates at 371C. After 4 d of culture, lymphocyte proliferation was
measured by pulsing the cells with 1 mCi of [3H] methylthymidine (5
Ci per mmol, Amersham, Les Ulis, France) for the final 18 h of
culture. Cells were then harvested and incorporated thymidine was
quantitated in a direct beta counter (Matrix 96, Packard Instru-
ments, Meriden, Connecticut). Results were expressed as the
mean counts per minute (cpm)þSD of triplicate cultures.
Statistical analysis Results were analyzed for statistical signifi-
cance using Student’s t test. Values of po0.05 were considered
statistically significant.
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